179 related articles for article (PubMed ID: 35498541)
1. BCKDK Promotes Ovarian Cancer Proliferation and Migration by Activating the MEK/ERK Signaling Pathway.
Li H; Yu D; Li L; Xiao J; Zhu Y; Liu Y; Mou L; Tian Y; Chen L; Zhu F; Duan Q; Xue P
J Oncol; 2022; 2022():3691635. PubMed ID: 35498541
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of BCKDK of BCAA catabolism at Y246 by Src promotes metastasis of colorectal cancer.
Tian Q; Yuan P; Quan C; Li M; Xiao J; Zhang L; Lu H; Ma T; Zou L; Wang F; Xue P; Ni X; Wang W; Liu L; Wang Z; Zhu F; Duan Q
Oncogene; 2020 May; 39(20):3980-3996. PubMed ID: 32238881
[TBL] [Abstract][Full Text] [Related]
3. BCKDK of BCAA Catabolism Cross-talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal Cancer.
Xue P; Zeng F; Duan Q; Xiao J; Liu L; Yuan P; Fan L; Sun H; Malyarenko OS; Lu H; Xiu R; Liu S; Shao C; Zhang J; Yan W; Wang Z; Zheng J; Zhu F
EBioMedicine; 2017 Jun; 20():50-60. PubMed ID: 28501528
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway.
Liu J; Hu HB; Liu YM; Li FX; Zhang LP; Liao ZM
Mol Med Rep; 2020 Nov; 22(5):3667-3676. PubMed ID: 33000231
[TBL] [Abstract][Full Text] [Related]
5. Loss of BCAA catabolism enhances Rab1A-mTORC1 signaling activity and promotes tumor proliferation in NSCLC.
Xue M; Xiao J; Jiang W; Wang Y; Zuo D; An H; Ren L
Transl Oncol; 2023 Aug; 34():101696. PubMed ID: 37216755
[TBL] [Abstract][Full Text] [Related]
6. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
7. Inhibiting BCKDK in triple negative breast cancer suppresses protein translation, impairs mitochondrial function, and potentiates doxorubicin cytotoxicity.
Biswas D; Slade L; Duffley L; Mueller N; Dao KT; Mercer A; Pakkiriswami S; El Hiani Y; Kienesberger PC; Pulinilkunnil T
Cell Death Discov; 2021 Sep; 7(1):241. PubMed ID: 34526485
[TBL] [Abstract][Full Text] [Related]
8. MiR-425-5p accelerated the proliferation, migration, and invasion of ovarian cancer cells via targeting AFF4.
Wu Z; Guo J; Zhang Y; Liu J; Ma H; Tang Y
J Ovarian Res; 2021 Oct; 14(1):138. PubMed ID: 34686190
[TBL] [Abstract][Full Text] [Related]
9. BCKDK alters the metabolism of non-small cell lung cancer.
Wang Y; Xiao J; Jiang W; Zuo D; Wang X; Jin Y; Qiao L; An H; Yang L; Dumoulin DW; Dempke WCM; Best SA; Ren L
Transl Lung Cancer Res; 2021 Dec; 10(12):4459-4476. PubMed ID: 35070754
[TBL] [Abstract][Full Text] [Related]
10. PRR11 Overexpression Facilitates Ovarian Carcinoma Cell Proliferation, Migration, and Invasion Through Activation of the PI3K/AKT/β-Catenin Pathway.
Zhu J; Hu H; Wang J; Yang Y; Yi P
Cell Physiol Biochem; 2018; 49(2):696-705. PubMed ID: 30165366
[TBL] [Abstract][Full Text] [Related]
11. FBXL18 is required for ovarian cancer cell proliferation and migration through activating AKT signaling.
Zhuang Y; Xue J; Qiu X; Zhu Y; Lv J; Xia F
Am J Transl Res; 2024; 16(5):1977-1990. PubMed ID: 38883375
[TBL] [Abstract][Full Text] [Related]
12. TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells.
Weng H; Feng X; Lan Y; Zheng Z
J Ovarian Res; 2021 Jun; 14(1):82. PubMed ID: 34162426
[TBL] [Abstract][Full Text] [Related]
13. A transcription factor that promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of ovarian cancer cells and its possible mechanisms.
Qi Y; Mo K; Zhang T
Biomed Eng Online; 2021 Aug; 20(1):83. PubMed ID: 34399777
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA PRNCR1 promotes ovarian cancer cell proliferation, migration and invasion by targeting the miR-653-5p/ELF2 axis.
Qi X; Chen D; Yu W; Wang L; Liu L; Tao X
Mol Cell Biochem; 2022 May; 477(5):1463-1475. PubMed ID: 35166984
[TBL] [Abstract][Full Text] [Related]
15. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
16. B7-H6 Promotes Cell Proliferation, Migration and Invasion of Non-Hodgkin Lymphoma via Ras/MEK/ERK Pathway Based on Quantitative Phosphoproteomics Data.
Yang S; Yuan L; Wang Y; Zhu M; Wang J; Ke X
Onco Targets Ther; 2020; 13():5795-5805. PubMed ID: 32606790
[TBL] [Abstract][Full Text] [Related]
17. TPX2 promotes cell proliferation and migration via PLK1 in OC.
Ma S; Rong X; Gao F; Yang Y; Wei L
Cancer Biomark; 2018; 22(3):443-451. PubMed ID: 29865033
[TBL] [Abstract][Full Text] [Related]
18. IGF2BP3‑stabilized SIX4 promotes the proliferation, migration, invasion and tube formation of ovarian cancer cells.
Han J; Hu X
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35616130
[TBL] [Abstract][Full Text] [Related]
19. BCKDK regulates breast cancer cell adhesion and tumor metastasis by inhibiting TRIM21 ubiquitinate talin1.
Xu C; Yang K; Xuan Z; Li J; Liu Y; Zhao Y; Zheng Z; Bai Y; Shi Z; Shao C; Zhang L; Sun H
Cell Death Dis; 2023 Jul; 14(7):445. PubMed ID: 37460470
[TBL] [Abstract][Full Text] [Related]
20. The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p.
Wang L; Ren C; Xu Y; Yang L; Chen Y; Zhu Y
J Ovarian Res; 2021 Jun; 14(1):77. PubMed ID: 34116704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
